GNS.LSE · Genus plc

-

Please sign in to comment on GNS.LSE

1 Comment

Admin

4 years ago

Genus plc is currently in a long term uptrend where the price is trading 9.3% above its 200 day moving average.

From a valuation standpoint, the stock is 98.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.7.

Genus plc's total revenue sank by 0.0% to $135M since the same quarter in the previous year.

Its net income has dropped by 0.0% to $12M since the same quarter in the previous year.

Finally, its free cash flow grew by 120.0% to $14M since the same quarter in the previous year.

Based on the above factors, Genus plc gets an overall score of 3/5.

Exchange	LSE
CurrencyCode	GBP
ISIN	GB0002074580
Sector	Healthcare
Industry	Biotechnology

PE Ratio	None
Target Price	2458.333
Dividend Yield	2.0%
Beta	0.6
Market Cap	1B

ABOUT

Genus plc

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands. Further, it offers technical services to farmers. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.

GNS.LSE · Genus plc

-

Genus plc

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Genus plc using a moving average strategy